Laryngeal Cancer Therapeutics Market by Type and Geography - Forecast and Analysis 2021-2025
- Published: Feb 2021
- Pages: 120
- SKU: IRTNTR70041
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The laryngeal cancer therapeutics market share is expected to increase by USD 635.07 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7%.
This laryngeal cancer therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers laryngeal cancer therapeutics market segmentation by type (biologics and small molecules) and geography (North America, Europe, Asia, and ROW). The laryngeal cancer therapeutics market report also offers information on several market vendors, including Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, and Spectrum Pharmaceuticals Inc. among others.
What will the Laryngeal Cancer Therapeutics Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Laryngeal Cancer Therapeutics Market Size for the Forecast Period and Other Important Statistics
Laryngeal Cancer Therapeutics Market: Key Drivers, Trends, and Challenges
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increasing prevalence of laryngeal cancer is notably driving the laryngeal cancer therapeutics market growth, although factors such as preference for alternative therapies may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the laryngeal cancer therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Laryngeal Cancer Therapeutics Market Driver
One of the key factors driving growth in the laryngeal cancer therapeutics market is the increasing prevalence of laryngeal cancer. The increase in smoking and the consumption of tobacco products have resulted in increased incidences of laryngeal cancer. Moreover, there is also an increase in the incidence of HPV-caused cancers. These factors coupled with the high mortality rate have led to the growing demand for therapeutics such as chemotherapy and targeted therapy for laryngeal cancer treatment. Because of factors such as the increasing prevalence of laryngeal cancer and the advent of novel therapies, the laryngeal cancer therapeutics market.
Key Laryngeal Cancer Therapeutics Market Trend
The high mortality rate and the increasing prevalence of laryngeal cancer have resulted in a growing need for novel therapeutics. Several pharmaceutical companies have undertaken research and development on novel PD-1 inhibitors, PD-L1 inhibitors which is associated with head and neck cancers. The development of gene therapy is also in the early stages of development. It involves the modification of the mutated gene to reverse the damage caused by the indication. The advent of novel therapies will be a critical trend that will have a positive impact on laryngeal cancer therapeutics market growth.
This laryngeal cancer therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Who are the Major Laryngeal Cancer Therapeutics Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Amgen Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Spectrum Pharmaceuticals Inc.
This statistical study of the laryngeal cancer therapeutics market encompasses successful business strategies deployed by the key vendors. The laryngeal cancer therapeutics market is fragmented and the vendors are deploying growth strategies such as focusing on R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The laryngeal cancer therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Which are the Key Regions for Laryngeal Cancer Therapeutics Market?
For more insights on the market share of various regions Request for a FREE sample now!
43% of the market's growth will originate from North America during the forecast period. The US is one of the key markets for laryngeal cancer therapeutics in North America. Market growth in this region will be slower than the growth of the market in Asia.
The increasing preference for therapeutics to treat various head and neck cancer indications is one of the prime factors that will facilitate the laryngeal cancer therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
What are the Revenue-generating Type Segments in the Laryngeal Cancer Therapeutics Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The laryngeal cancer therapeutics market share growth by the biologics segment will be significant during the forecast period. Due to the strong stability of biologics, treatment using these drugs is often very effective and has minimal to no side effects. As a result, the biologics segment of the global laryngeal cancer therapeutics market has witnessed significant growth in recent years. The growth of the market segment is expected to continue to be significant during the forecast period
This report provides an accurate prediction of the contribution of all the segments to the growth of the laryngeal cancer therapeutics market size and actionable market insights on post COVID-19 impact on each segment.
You may be interested in:
Throat Cancer Therapeutics market - The market size is predicted to surge to USD 1.82 billion from 2021 to 2026 at a CAGR of 6.7%.
Laryngeal Cancer Therapeutics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7% |
Market growth 2021-2025 |
$ 635.07 million |
Market structure |
Fragmented |
YoY growth (%) |
6.10 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 43% |
Key consumer countries |
US, Germany, UK, France, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, and Spectrum Pharmaceuticals Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Laryngeal Cancer Therapeutics Market Report?
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive laryngeal cancer therapeutics market growth during the next five years
- Precise estimation of the laryngeal cancer therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the laryngeal cancer therapeutics industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of laryngeal cancer therapeutics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Biologics - Market size and forecast 2020-2025
- Small molecules - Market size and forecast 2020-2025
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Amgen Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Spectrum Pharmaceuticals Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Germany
- UK
- France
- Japan
- Increasing prevalence of laryngeal cancer
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
